Targeting ceramide synthesis to reverse insulin resistance.
about
Endothelial fatty acid transport: role of vascular endothelial growth factor B(n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insightsMetabolic remodeling of white adipose tissue in obesityIs Alzheimer's disease a systemic disease?A high-throughput sphingomyelinase assay using natural substrate.Metabolic syndrome as a risk factor for neurological disorders.Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes.Cellular mechanism of insulin resistance in nonalcoholic fatty liver diseaseAcid sphingomyelinase gene deficiency ameliorates the hyperhomocysteinemia-induced glomerular injury in mice.CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistanceEffects on muscle tissue remodeling and lipid metabolism in muscle tissue from adult patients with polymyositis or dermatomyositis treated with immunosuppressive agents.Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides.Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy.High-fat diet differentially regulates metabolic parameters in obesity-resistant S5B/Pl rats and obesity-prone Osborne-Mendel rats.Ceramide and insulin resistance: how should the issue be approached?Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells.Ceramide accumulation in L6 skeletal muscle cells due to increased activity of ceramide synthase isoforms has opposing effects on insulin action to those caused by palmitate treatment.Effects of meal ingestion on intramyocellular ceramide concentrations and fractional de novo synthesis in humans.Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview.
P2860
Q26829121-C5FEFF41-1901-4C95-8276-C5215136E20CQ27013554-2A65B442-676E-464B-943F-8E0A76DA2B7EQ34001327-A65017AD-1C68-4D1D-8BD5-E403AD87AB84Q34019193-D226A137-106B-4ED5-A6F0-433AEA26E571Q34068492-D7A35995-E895-4291-8066-BB8821B020AAQ34224030-981541FA-8721-4606-9DFD-A138F1AFCA75Q34302721-5E78D076-2A0C-4F71-A53C-DB3A4EFF06D0Q35239565-A8E141AA-4D93-4C6B-B1A9-9A0CA54A9041Q35474438-799AD478-5903-457B-82A7-F327620288EEQ36583167-9A495EBE-C7E0-49F7-B56A-817AF1B6E3A7Q36994516-9C9AB877-D022-4AF9-A871-8E83C579440CQ37339555-D0FD2E94-0A09-4A12-ABD9-2B87ECAA7050Q38831906-BB359892-F0E2-4570-935F-C83E799A52E1Q40238209-95414DDA-EC1B-402F-A320-58057B6BAB6BQ41533503-FBB2AF48-59D7-47B5-AC72-CFC5D3A62AD1Q42145401-085630BC-0B72-4C79-A3A4-40F827AA4157Q47671597-EFDE343C-F596-4DE5-A171-46C48BD99AE8Q47879924-95067253-65ED-4C65-AC69-1151A6317D22Q55278796-C34B0E4A-8563-4A0C-BACA-A61F560E7DF4
P2860
Targeting ceramide synthesis to reverse insulin resistance.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Targeting ceramide synthesis to reverse insulin resistance.
@ast
Targeting ceramide synthesis to reverse insulin resistance.
@en
type
label
Targeting ceramide synthesis to reverse insulin resistance.
@ast
Targeting ceramide synthesis to reverse insulin resistance.
@en
prefLabel
Targeting ceramide synthesis to reverse insulin resistance.
@ast
Targeting ceramide synthesis to reverse insulin resistance.
@en
P2860
P356
P1433
P1476
Targeting ceramide synthesis to reverse insulin resistance
@en
P2093
Carsten Schmitz-Peiffer
P2860
P304
P356
10.2337/DB10-0912
P407
P577
2010-10-01T00:00:00Z